Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
2050057-56-0
Purity
95%
Upadacitinib is an oral selective inhibitor of tyrosine-protein kinase JAK1 and a disease-modifying antirheumatic drug. It is used in the treatment of rheumatoid arthritis to slow down disease progression.
Properties
Name
Upadacitinib hemihydrate
Smiles
O.CC[C@@H]1CN(C[C@@H]1C2=CN=C3C=NC=4NC=CC4N23)C(=O)NCC(F)(F)F.CC[C@@H]1CN(C[C@@H]1C2=CN=C3C=NC=4NC=CC4N23)C(=O)NCC(F)(F)F
Targets
Please log in to see this information
SDS
ABT-494 | upadacitinib
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$121
2 mg
$127
5 mg
$138
10 mg
$153
15 mg
$216
20 mg
$278
25 mg
$345
30 mg
$389
35 mg
$433
40 mg
$472
45 mg
$520
50 mg
$558
75 mg
$816
100 mg
$928
Quantity
1
Total amount
$ 138
ABT-494 | upadacitinib
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.